Crossmark

Real clinical setting intravenous ketamine use for treatment resistant depression: 12 month follow-up after initial response

Crossref DOI link: https://doi.org/10.1016/j.rpsmen.2021.11.004

Published Print: 2021-10

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Olazabal, Nora

Bustamante, Sonia

Madrazo, M. Aranzazu

Osa, Luis

O’Neill of Tyrone, Ana M.

Catalán, Ana

González-Torres, Miguel Angel
License Information

Text and Data Mining valid from 2021-10-01
More Information

This article is maintained by: Elsevier

Article Title: Real clinical setting intravenous ketamine use for treatment resistant depression: 12 month follow-up after initial response

Journal Title: Revista de Psiquiatría y Salud Mental (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.rpsmen.2021.11.004

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.rpsm.2021.01.002

Content Type: simple-article

Copyright: © 2021 SEP y SEPB. Published by Elsevier España, S.L.U. All rights reserved.